Inhibiting MARSs reduces hyperhomocysteinemia‐associated neural tube and congenital heart defects

Abstract

Hyperhomocysteinemia is a common metabolic disorder that imposes major adverse health consequences. Reducing homocysteine levels, however, is not always effective against hyperhomocysteinemia‐associated pathologies. Herein, we report the potential roles of methionyl‐tRNA synthetase (MARS)‐generated homocysteine signals in neural tube defects (NTDs) and congenital heart defects (CHDs). Increased copy numbers of MARS and/or MARS2 were detected in NTD and CHD patients. MARSs sense homocysteine and transmit its signal by inducing protein lysine (N)‐homocysteinylation. Here, we identified hundreds of novel N‐homocysteinylated proteins. N‐homocysteinylation of superoxide dismutases (SOD1/2) provided new mechanistic insights for homocysteine‐induced oxidative stress, apoptosis and Wnt signalling deregulation. Elevated MARS expression in developing and proliferating cells sensitizes them to the effects of homocysteine. Targeting MARSs using the homocysteine analogue acetyl homocysteine thioether (AHT) reversed MARS efficacy. AHT lowered NTD and CHD onsets in retinoic acid‐induced and hyperhomocysteinemia‐induced animal models without affecting homocysteine levels. We provide genetic and biochemical evidence to show that MARSs are previously overlooked genetic determinants and key pathological factors of hyperhomocysteinemia, and suggest that MARS inhibition represents an important medicinal approach for controlling hyperhomocysteinemia‐associated diseases.

Homocysteine aggravates DNA damage by impairing the FA/Brca1 Pathway in NE4C murine neural stem cells

“…A new mechanism, “protein N-homocysteinylation” (Hcy-N-protein), has recently emerged and is considered to be the major cause of cardiovascular and neurological degenerative disorders in humans 4 , 50 . Plasma Hcy-N-protein is positively related to plasma Hcy.…”

A Proteogenomic Atlas of Clear Cell Renal Cell Carcinoma in a Chinese Population

“…6C) levels were increased in ccRCC tumors compared to adjacent tissues. In our previous cell-wide proteomics screen for K-Hcy substrates in HEK293T cells, we observed that DNA-PKcs, a protein required for the non-homologous endjoining pathway of DNA repair, was heavily modi ed by K-Hcy 47,48 . In ccRCC tumors, we validated that three different lysine residues (K122, K712, K868, and K902) were modi ed by K-Hcy ( Fig.…”

“…7O). In addition, increased NNMT expression in 786-O and ACHN promoted xenograft tumor growth in nude mice, especially in IR-treated cell xenografts, whereas inhibition of K-Hcy by intraperitoneal injection of N-acetyl-cysteine (NAC) 47,48 delayed xenograft growth (Figs. 7P, Q).…”

Homocysteine inhibits pro-insulin receptor cleavage and causes insulin resistance via protein cysteine-homocysteinylation

“…We observed that Hcy modified the lysine residue of proteins and signaled by the formation of protein lysine-Hcy (K-Hcy). K-Hcy inhibited superoxide dismutase 1 (SOD1) and SOD2 activities and increased the levels of reactive oxygen species (Mei et al, 2020). In addition, K-Hcy inactivates the ATR-mediated DNA damage repair pathway, resulting in the accumulation of DNA damage (Wang et al, 2018).…”